Proxima Therapeutics Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$160M
Proxima Therapeutics General Information
Description
Developer of radiation delivery systems for the treatment of cancer. The company develops radiation delivery systems in the treatment of solid cancerous tumors for brain and breast cancer, providing medical practitioners with tools that are used for breast conservation therapy.
Contact Information
Website
www.proximatherapeutics.comCorporate Office
- 2555 Marconi Drive
- Suite 220
- Alpharetta, GA 30005
- United States
Corporate Office
- 2555 Marconi Drive
- Suite 220
- Alpharetta, GA 30005
- United States
Proxima Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 07-Mar-2005 | $160M | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series E) | 16-Aug-2002 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 02-Feb-2001 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 01-Jan-1998 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Apr-1997 | $4M | $4.8M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Aug-1995 | $800K | $800K | Completed | Product Development |
Proxima Therapeutics Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Partners | Venture Capital | Minority | ||
| BofA Securities | Investment Bank | Minority | ||
| Catalyst Ventures | Venture Capital | Minority | ||
| Domain Associates | Venture Capital | Minority | ||
| Greenspring Associates | Venture Capital | Minority |
Proxima Therapeutics FAQs
-
When was Proxima Therapeutics founded?
Proxima Therapeutics was founded in 1995.
-
Where is Proxima Therapeutics headquartered?
Proxima Therapeutics is headquartered in Alpharetta, GA.
-
What industry is Proxima Therapeutics in?
Proxima Therapeutics’s primary industry is Drug Delivery.
-
Is Proxima Therapeutics a private or public company?
Proxima Therapeutics is a Private company.
-
What is the current valuation of Proxima Therapeutics?
The current valuation of Proxima Therapeutics is .
-
What is Proxima Therapeutics’s current revenue?
The current revenue for Proxima Therapeutics is .
-
How much funding has Proxima Therapeutics raised over time?
Proxima Therapeutics has raised $47.1M.
-
Who are Proxima Therapeutics’s investors?
Alta Partners, BofA Securities, Catalyst Ventures, Domain Associates, and Greenspring Associates are 5 of 11 investors who have invested in Proxima Therapeutics.
-
When was Proxima Therapeutics acquired?
Proxima Therapeutics was acquired on 07-Mar-2005.
-
Who acquired Proxima Therapeutics?
Proxima Therapeutics was acquired by Cytyc.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process